Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on April 7, 2025
AFC Urgent Care Coppell Open, Accepting Patients
EIN Presswire
·
April 7, 2025
AFC Urgent Care Coppell open, offering quick, affordable care. Extended hours, wide services, and myAFC membership available. COPPELL, TX, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- AFC Urgent Care Coppell is now open to serve our community, …
35th Annual National Suicide Prevention Conference in Richmond Hill, Ontario
GlobeNewswire
·
April 7, 2025
RICHMOND HILL, Ontario, April 07, 2025 (GLOBE NEWSWIRE) -- The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the 35th Annual National Suicide Prevention Conference, scheduled to take place May 14 - 16, 2025, at the Sheraton …
TravelingWiki Meets with Duke Basketball's Ryan Young; Corey Saffold, Star Profiled by ESPN 30 For 30, During Final Four
EIN Presswire
·
April 7, 2025
SAN ANTONIO, TX, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- During the days surrounding the NCAA Final Four, TravelingWiki had an extensive set of engagements surrounding the Final Four NCAA Tournament to promote special needs awareness, …
Tanke Biosciences Corp Announces the Appointment of John P. Hopkins Executive Chairman of the Board of Directors
GlobeNewswire
·
April 7, 2025
Las Vegas, Nevada, April 07, 2025 (GLOBE NEWSWIRE) -- Tanke Biosciences Corp (the “Company”) (OTC: TNBI) announced today that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, effective March 31st, 2025. Mr. Hopkins …
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds
GlobeNewswire
·
April 7, 2025
ACTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings …
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
GlobeNewswire
·
April 7, 2025
SOUTH JORDAN, Utah, April 07, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 7, 2025
BEDFORD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis (“OA”) Pain Management and Regenerative Solutions space focused on early intervention orthopedics, today announced that on …
PainReform Provides Year-End Business Update
GlobeNewswire
·
April 7, 2025
TEL AVIV, Israel, April 07, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a specialty pharmaceutical company focused on the reformulation of established therapeutics and commercialization of the DeepSolar …
Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
GlobeNewswire
·
April 7, 2025
Auditor Licensing …
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
GlobeNewswire
·
April 7, 2025
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …
Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
GlobeNewswire
·
April 7, 2025
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …
Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
GlobeNewswire
·
April 7, 2025
-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …
CareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)
GlobeNewswire
·
April 7, 2025
NEW HYDE PARK, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CareMed, an independent specialty pharmacy, is in the Limited Distribution Network for Vanrafia™ (atrasentan), for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy ( …
Solésence Announces Uplisting to Nasdaq
GlobeNewswire
·
April 7, 2025
Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today …
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 7, 2025
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
GlobeNewswire
·
April 7, 2025
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …
CVRx Reports Preliminary First Quarter 2025 Financial Results
GlobeNewswire
·
April 7, 2025
MINNEAPOLIS, April 07, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced certain preliminary unaudited first quarter 2025 revenue results. “While we continue to make significant progress …
Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage
GlobeNewswire
·
April 7, 2025
WILMINGTON, Del., April 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced the appointment of Dr. Shelly Gupta as Chief Medical Officer (“CMO”). Dr. Gupta will oversee …
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
GlobeNewswire
·
April 7, 2025
WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified by a commitment to advancing patient- …
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025
GlobeNewswire
·
April 7, 2025
BURLINGTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2025 financial results on Thursday, May 1, 2025, after the market close. The company has scheduled a …